
    
      The study will consist of a group of subjects who have been on bosentan for at least three
      months and a group that has been on macitentan for at least three months. Both groups will be
      switched to Letairis 5mg daily after the bosentan or macitentan therapy for three months and
      then increased to a dose of Letairis 10mg daily at week 4 if well tolerated.
    
  